Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
December 1, 2016
Inter-individual variability and modeling of electrical activity: a possible new approach to explore cardiac safety?
Jean-Yves Le Guennec, Jérôme Thireau, Aude Ouillé, et al.
British Journal of Pharmacology
|
January 19, 2005
Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres
Pascal Champeroux, Karen Viaud, Abdel Ilah El Amrani, et al.
Plos One
|
January 10, 2013
Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model
Laura Brullé, Marc Vandamme, Delphine Riès, et al.
Journal of Pharmacological and Toxicological Methods
|
May 31, 2023
Thirty years of telemetry-based data acquisition for cardiovascular drug safety evaluation: Applications and optimization
Elham Ataei Alizadeh, Karin Graf, Jessica Schiwon, et al.
Journal of Pharmacological and Toxicological Methods
|
February 23, 2010
Interferences of the autonomic nervous system with drug induced QT prolongation: a point to consider in non-clinical safety studies
Pascal Champeroux, Aude Ouillé, Eric Martel, et al.
Investigative Radiology
|
January 16, 2007
Cardiovascular safety of gadoterate meglumine (Gd-DOTA)
Philippe Bourrinet, Eric Martel, Abdel I El Amrani, et al.
Journal of Pharmacological and Toxicological Methods
|
February 26, 2013
Power spectral analysis of heart rate variability in cynomolgus monkeys in safety pharmacology studies: comparative study with beagle dogs
Pascal Champeroux, Eric Martel, Sebastien Jude, et al.
Clinical Pharmacology and Therapeutics
|
May 6, 2024
Results from a Joined Prospective Study to Evaluate the Sensitivity of the In Vivo Dog QT Assay in Line with the ICH E14/S7B Q&A Best Practices
Anne-Marie Bétat, Annie Delaunois, Eric Delpy, et al.
Carcinogenesis
|
November 25, 2011
Reducing endothelial NOS activation and interstitial fluid pressure with n-3 PUFA offset tumor chemoresistance
Sophie Kornfeld, Caroline Goupille, Sophie Vibet, et al.
Journal of Pharmacological and Toxicological Methods
|
January 13, 2009
Calculation of QT shift in non clinical safety pharmacology studies
Pascal Champeroux, Eric Martel, John Sinclair Lawrence Fowler, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
December 1, 2016
Inter-individual variability and modeling of electrical activity: a possible new approach to explore cardiac safety?
Jean-Yves Le Guennec, Jérôme Thireau, Aude Ouillé, et al.
British Journal of Pharmacology
|
January 19, 2005
Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres
Pascal Champeroux, Karen Viaud, Abdel Ilah El Amrani, et al.
Plos One
|
January 10, 2013
Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model
Laura Brullé, Marc Vandamme, Delphine Riès, et al.
Journal of Pharmacological and Toxicological Methods
|
May 31, 2023
Thirty years of telemetry-based data acquisition for cardiovascular drug safety evaluation: Applications and optimization
Elham Ataei Alizadeh, Karin Graf, Jessica Schiwon, et al.
Journal of Pharmacological and Toxicological Methods
|
February 23, 2010
Interferences of the autonomic nervous system with drug induced QT prolongation: a point to consider in non-clinical safety studies
Pascal Champeroux, Aude Ouillé, Eric Martel, et al.
Investigative Radiology
|
January 16, 2007
Cardiovascular safety of gadoterate meglumine (Gd-DOTA)
Philippe Bourrinet, Eric Martel, Abdel I El Amrani, et al.
Journal of Pharmacological and Toxicological Methods
|
February 26, 2013
Power spectral analysis of heart rate variability in cynomolgus monkeys in safety pharmacology studies: comparative study with beagle dogs
Pascal Champeroux, Eric Martel, Sebastien Jude, et al.
Clinical Pharmacology and Therapeutics
|
May 6, 2024
Results from a Joined Prospective Study to Evaluate the Sensitivity of the In Vivo Dog QT Assay in Line with the ICH E14/S7B Q&A Best Practices
Anne-Marie Bétat, Annie Delaunois, Eric Delpy, et al.
Carcinogenesis
|
November 25, 2011
Reducing endothelial NOS activation and interstitial fluid pressure with n-3 PUFA offset tumor chemoresistance
Sophie Kornfeld, Caroline Goupille, Sophie Vibet, et al.
Journal of Pharmacological and Toxicological Methods
|
January 13, 2009
Calculation of QT shift in non clinical safety pharmacology studies
Pascal Champeroux, Eric Martel, John Sinclair Lawrence Fowler, et al.
Page
of 3